Glen Harbor Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-640
Closed -$29K 1276
2018
Q1
$29K Buy
+640
New +$29K ﹤0.01% 1256